BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Gain Therapeutics\, Inc. (GANX) investor events
X-WR-CALNAME:Gain Therapeutics\, Inc. (GANX) investor events
DESCRIPTION:Earnings calls and investor events for Gain Therapeutics\, Inc.
  (GANX)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Gain Therapeutics\, Inc
 . (GANX)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:0dcc7999-c9c3-4aa5-b2f8-2318a5c0c8a1@equibles.com
DTSTAMP:20260617T191305Z
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:edc57fc3-27a9-401c-b435-5e29e1e053bb@equibles.com
DTSTAMP:20261002T212448Z
DTSTART;VALUE=DATE:20260106
DTEND;VALUE=DATE:20260107
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Investor Update: Parkinson’s Dise
 ase KOL Event: Understanding GCase Substrates in Parkinson’s Disease –
  Perspectives on Biomarkers and Disease Modification
DESCRIPTION:Parkinson’s Disease KOL Event: Understanding GCase Substrates
  in Parkinson’s Disease – Perspectives on Biomarkers and Disease Modif
 ication\nThe start time has not been announced.\nWebcast: https://gainther
 apeutics.com/newsroom/events/parkinsons-disease-kol-event-understanding-gc
 ase-substrates-in-parkinsons-disease-perspectives-on-biomarkers-and-diseas
 e-modification/
END:VEVENT
BEGIN:VEVENT
UID:a5308f95-6101-4020-9562-103cc44550f7@equibles.com
DTSTAMP:20260624T233115Z
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Conference: Oppenheimer Fireside Ch
 at with President and CEO Gene Mack – 36th Annual Healthcare Life Scienc
 es Conference
DESCRIPTION:Oppenheimer Fireside Chat with President and CEO Gene Mack – 
 36th Annual Healthcare Life Sciences Conference\nThe start time has not be
 en announced.\nWebcast: https://event.summitcast.com/view/CTtthLh2Bi2D9aYo
 KpvtEv/guest_book?session_id=7YrQBcWEuCgckCDoVYSHNv
URL:https://equibles.com/stocks/ganx/events/a5308f95-6101-4020-9562-103cc44
 550f7
END:VEVENT
BEGIN:VEVENT
UID:79e149b6-694e-475f-975b-f68e22503404@equibles.com
DTSTAMP:20260617T191055Z
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260324
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/ganx/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:0ad13217-d916-4934-a947-6fc2e840ff6b@equibles.com
DTSTAMP:20260617T191047Z
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260512
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:b1103b61-666a-4535-85bc-56d8a320e501@equibles.com
DTSTAMP:20260917T221907Z
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260915
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Gain Therapeutics\, Inc. (GANX) Conference: H.C. Wainwright 28th An
 nual Global Investment Conference Company Presentation with President and 
 CEO Gene Mack
DESCRIPTION:H.C. Wainwright 28th Annual Global Investment Conference Compan
 y Presentation with President and CEO Gene Mack\nThe start time has not be
 en announced.\nWebcast: https://event.summitcast.com/view/kKmFFrbEes9oUCyr
 RFmQ5N/guest_book?session_id=dhHqmRbm6oBzayvVowEgit
END:VEVENT
END:VCALENDAR